In osteosarcoma, sorafenib inhibits the proliferation of tumor, angiogenesis (VEGF), invasion (MMP2), the emergence of pulmonary metastases (Erzin/β4-integrin/ PI3K) and induces apoptosis [23]. The gene discussed is MMP2; the disease is neoplasm.